| Health / Medical Topics |
PSA-OP Peptide Vaccine
A 30-residue prostate specific antigen (PSA) oligoepitope peptide (OP) vaccine with potential antineoplastic activity. PSA-OP peptide vaccine contains the PSA-1 and PSA-3 HLA-A2 epitopes and the PSA-9 HLA-class I-A3 epitope joined by peptide linker sequences. In an animal model, vaccination with this agent has been shown to elicit a cytotoxic T-lymphocyte immune response. (NCI Thesaurus)
YOU MAY ALSO LIKE
A measurement of how fast PSA levels in the blood increase over time. A high PSA velocity may be a sign of…
A laboratory test that measures the amount of prostate-specific antigen (PSA) found in the blood. PSA is a protein made by the…
An autologous dendritic cell vaccine with potential immunostimulatory activity. Dendritic cells harvested from a prostate cancer patient are transfected with the mRNA…
A peptide vaccine containing the prostate specific antigen (PSA) with potential antineoplastic activity. PSA, a glycoprotein secreted by prostatic epithelial and ductal…
A rise in the blood level of PSA (prostate-specific antigen) in prostate cancer patients after treatment with surgery or radiation. PSA failure…
A brief rise and then fall in the blood level of PSA (prostate-specific antigen) that occurs in some patients 1-3 years after…
